President Trump's Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else
The order aims to ease medical research and reduce industry barriers, with nearly 20% of Americans using marijuana annually, according to the CDC.
- On December 18, 2025, President Donald Trump signed an executive order directing federal agencies to move marijuana from Schedule I to Schedule III and instructed Attorney General Pam Bondi to complete rulemaking.
- Senior administration officials said the order's main aim was to increase medical research, following a Department of Health and Human Services review begun under the prior administration.
- Under current rules, cannabis businesses face Section 280E tax treatment pushing effective rates near 75% or 80%, while rescheduling would allow normal expense deductions and Schedule III tax breaks.
- Stocks reacted immediately, with cannabis stocks falling between 3% and 12% at Thursday's close, amid opposition from Twenty-one Senate Republicans including Ted Budd; implementation could extend into most of 2026, with Oklahoma's moratorium lasting until Aug. 1, 2026.
- Despite rescheduling, FDA approval and congressional action remain important for cross-state sales and stable rules, though the order could unlock research funding and improve access to capital.
36 Articles
36 Articles
Bipartisan Majority Of Americans Support Rescheduling Marijuana And Say It Has Medical Value, New Poll Finds After Trump Takes Action
A bipartisan majority of Americans support federally rescheduling marijuana, according to a new poll. And most also believe it should be entirely legal for adults to use cannabis. The YouGov survey was released just days after President Donald Trump directed the attorney general to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). The reform wouldn’t legalize cannabis, …
A Christmas Message to the DEA's Diversion Anti Marijuana Cabal
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It was about ideology. Control. And a refusal to accept science that challenged…
Marijuana rescheduling would bring some immediate changes, but others will take time
President Trump set the process in motion to ease federal restrictions on marijuana. But his order doesn't automatically revoke laws targeting marijuana, which remains illegal to transport over state lines.
Trump’s Marijuana Move Sparks Indiana Legalization Talk
Source: Anna Moneymaker / Getty INDIANAPOLIS — President Donald Trump’s move to relax federal marijuana rules is sparking new conversations about legalization in Indiana. Trump signed an executive order asking the U.S. attorney general to speed up reclassifying marijuana from Schedule I, alongside heroin and LSD, to Schedule III, like anabolic steroids. The change could make medical use easier, but the process could take time and face legal chal…
Arkansas officials say federal marijuana move would mainly affect research
President Donald Trump signed an executive order last week directing federal agencies to reclassify marijuana from a Schedule I to a Schedule III drug, a move drawing national attention and prompting questions about its impact in Arkansas. State leaders say the order does not legalize marijuana and does not override Arkansas law. “I don’t think anything in Arkansas has changed other than researchers who study the effects of medicine now will hav…
Executive order accelerates cannabis rescheduling timeline
Executive order accelerates cannabis rescheduling timeline JACKSON, Miss. (WLBT) – An executive order signed by President Donald Trump is set to fast-track the reclassification of cannabis. The recent executive order doesn’t legalize marijuana in any way, Robert Welch, director of the National Center for Cannabis Research and Education at Ole Miss, said. “A common misconception that we hear a lot is that, oh, it’s Schedule III now…so we can just…
Coverage Details
Bias Distribution
- 48% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium














